Neural Regenerative Potential of Stem Cells Derived from the Tooth Apical Papilla

Area of Science:

• Regenerative Medicine
• Neuroscience
• Stem Cell Biology

Background:

• Dental-derived stem cells, specifically stem cells from apical papilla (SCAP), have demonstrated regenerative capabilities.
• Nerve injury often leads to chronic pain and functional deficits, necessitating novel therapeutic strategies.

Purpose of the Study:

• To investigate the potential of human SCAP in promoting nerve regeneration and alleviating pain associated with nerve injury.
• To characterize the effects of interferon-gamma (IFN-γ) priming on SCAP behavior and their neurotrophic factor expression.

Main Methods:

• SCAP from nine individuals were isolated, characterized, and polarized with IFN-γ.
• In vitro studies involved co-culturing SCAP with rat dorsal root ganglion neurons.
• In vivo studies utilized a sciatic nerve chronic constriction injury model in Wistar rats, with local SCAP application.

Main Results:

• IFN-γ priming modulated SCAP's production of kynurenine, IL-6, BDNF, and GDNF.
• SCAP co-culture promoted neurite outgrowth and BDNF secretion from neurons.
• In vivo, SCAP treatment reduced hypersensitivity, pain scores, and partially restored myelin and BDNF levels in injured nerves.

Conclusions:

• Human SCAP possess significant nerve regenerative potential.
• SCAP therapy offers a promising avenue for managing nerve injury complications and associated pain.